GENX — Genex Pharmaceutical Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for Genex Pharmaceutical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2004 December 31st | 2005 December 31st | C2006 December 31st | 2007 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | 10KSB | 10KSB | 10KSB | 10KSB |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 0.326 | 0.296 | 0.192 | 0.43 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 1.86 | 3.49 | 0.882 | 1.22 |
| Total Inventory | ||||
| Total Current Assets | 2.71 | 4.24 | 1.53 | 2.14 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 0.23 | 0.178 | 0.131 | 0.196 |
| Other Long Term Assets | ||||
| Total Assets | 2.94 | 4.42 | 5.75 | 8.65 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 0.326 | 1.07 | 1.63 | 3.48 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 0.326 | 1.1 | 1.68 | 3.91 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 2.61 | 3.32 | 4.07 | 4.74 |
| Total Liabilities & Shareholders' Equity | 2.94 | 4.42 | 5.74 | 8.65 |
| Total Common Shares Outstanding |